Connection

Kent Armeson to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications Kent Armeson has written about Xenograft Model Antitumor Assays.
Kent Armeson
Connection Strength
0.066
Xenograft Model Antitumor Assays
  1. Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
    View in: PubMed
    Score: 0.040
  2. Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse. J Clin Invest. 2013 Oct; 123(10):4344-58.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.